STOCK TITAN

UNITED HEALTH PRODUTS INC - $UEEC STOCK NEWS

Welcome to our dedicated page for UNITED HEALTH PRODUTS news (Ticker: $UEEC), a resource for investors and traders seeking the latest updates and insights on UNITED HEALTH PRODUTS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect UNITED HEALTH PRODUTS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of UNITED HEALTH PRODUTS's position in the market.

Rhea-AI Summary
United Health Products, Inc. (UEEC) updates on FDA Premarket Approval application for absorbable hemostatic gauze.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.18%
Tags
none
-
Rhea-AI Summary
United Health Products (UEEC) reports positive results from product sterilization and stability testing for its hemostatic gauze, meeting acceptable bioburden levels for Class III products. The company will proceed with final drafting of the PMA documentation to be submitted for FDA and Health Canada review.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
Rhea-AI Summary
United Health Products provides an update on its FDA Premarket Approval application process, with packaging testing substantially completed and no non-conforming results. The company has been selected as the first medical device application to be evaluated using the FDA's eSTAR platform. This streamlined process may lead to more efficient premarket reviews and timely approval decisions. Additionally, UHP will test the use of a single eSTAR for approval from Health Canada, potentially expanding its market for human surgical applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
Rhea-AI Summary
United Health Products, Inc. provides an update on its FDA Premarket Approval application process. Testing delays by external service providers have caused further delays in the preparation and filing of the revised PMA application. Packaging activities completed so far have shown no adverse or unexpected results. Approval of the PMA application is not guaranteed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.26%
Tags
none
-
Rhea-AI Summary
United Health Products provides update on FDA Premarket Approval application process
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.87%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.88%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
none
UNITED HEALTH PRODUTS INC

OTC:UEEC

UEEC Rankings

UEEC Stock Data

49.98M
224.42M
8.93%
0.07%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Mesquite

About UEEC

united health products inc (ueec) is a capital markets company based out of 409 brevard ave, cocoa, fl, united states.